Navigation Links
Move Over Botox - Beverly Hills' Simoni Plastic Surgery to Hold the First Ever Dysport Party
Date:10/13/2009

BEVERLY HILLS, Calif., Oct. 13 /PRNewswire/ -- Botox® parties are so last year. With the recent FDA approval of Dysport, Botox® finally has its first and only rival. Consumers and the plastic surgery industry at large are expecting some changes to the anti-aging game as a result of this new competition. Many are hoping this rivalry between Botox® and Dysport will result in not only price reduction, but quality improvement, both of which will benefit consumers directly.

For years, Allergan's Botox® has dominated the market without any major competition. The unmatched and cost effective results provided by Botox® have made it the number one cosmetic procedure in America. No other aesthetic product is as popular nor has hosted as many parties throughout the country.

Botulinum toxin A is the active ingredient of both Dysport and Botox. The diluted Botulinum toxin A relaxes the muscles that cause wrinkles, decreasing unsightly lines. Allergan, the company behind Botox®, has enjoyed an unrivaled market for years, repeatedly raising its prices every year. Even the recent downturn in the economy has not seemed to diminish the need for this luxury item. "Interestingly the number of Botox® requests has increased in recent months," explains Dr. Payman Simoni, a Beverly Hills plastic surgeon. "As more people cannot afford costly surgical procedures, a temporary yet affordable fix has become more attractive," he said.

"With Dysport, medical manufacturer Ipsen introduces the only other FDA approved botulinum toxin, and the happy days of no competition may be over for Allergan," said Dr. Simoni. "This may spur on pricing competition that will benefit consumers. Also this competition may trigger further attempts to improve on to the next 'bigger and better' products," he concluded.

Payman Simoni, MD is a dual board certified plastic surgeon and the founder of Simoni Plastic Surgery, a Beverly Hills plastic surgery practice. He is the creator of the revolutionary procedure, the Simoni Lift, a one-hour comprehensive face lift that is performed without the need for general anesthesia. His revolutionary procedures have been featured in or on The New York Times, The View, Reuters, CNN, EXTRA, KTLA, Entertainment Tonight, The Insider, OK! Magazine, GMTV, 10 Years Younger, Telemundo, and The Orange County Register..

SOURCE Simoni Plastic Surgery


'/>"/>
SOURCE Simoni Plastic Surgery
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. MedShape Solutions, Inc. Appoints Jack Blair and Tom Hills to Board of Directors; Announces Additions to Management Team
2. Telik Announces Publication of Positive Phase 1 Results of a Multicenter Study of Ezatiostat Hydrochloride (TELINTRA(R), TLK199) Tablets In Patients With Myelodysplastic Syndrome
3. Accent on Aesthetics Plastic Surgery Medical Center Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler
4. FDA Accepts sNDA for Alternative Dosing Regimen for Dacogen(R) (decitabine for injection) to Treat Patients with Myelodysplastic Syndromes (MDS)
5. New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults
6. Plastic Surgeons Warn of Malnutrition in Body Contouring Patients
7. Eisai Provides Preliminary Efficacy Update On EORTC Phase III Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes
8. SuperGen Comments on Preliminary Efficacy Update on EORTC Phase 3 Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes
9. Vion Pharmaceuticals Announces Presentation of Data of Cloretazine(R) (VNP40101M) in Elderly Patients with High-Risk Myelodysplastic Syndromes at the EHA Annual Meeting
10. Got Fat?: Plastic Surgeons Review Fat-Melting and Fat-Grafting Procedures
11. Miami Plastic Surgeon Offers Hope to Acne Scarred Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... Sweden , April 20, 2017 ... NEVPF) ("NeuroVive") today announced positive preclinical results ... preclinical compound for non-alcoholic steatohepatitis (NASH), in ... NV556 has previously shown ... NASH model. Today, NeuroVive,s scientists present novel ...
(Date:4/19/2017)... April 19, 2017  IRIDEX Corporation (Nasdaq: ... results for the first quarter 2017 after the close ... management team will host a corresponding conference call beginning ... Investors interested in listening to the conference call ... callers or (703) 326-3030 for international callers, using conference ...
(Date:4/19/2017)...  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ... new treatments for cancer and other unmet medical ... announced underwritten public offering of 23,625,084 shares of ... of $2.00 per share, before deducting underwriting discounts ... Sorrento.  The net proceeds to Sorrento from this ...
Breaking Medicine Technology:
(Date:4/24/2017)... ... April 24, 2017 , ... symplrTM, a leading provider of ... that Kyle Allain has joined the company as Vice President and General Manager ... provider, payor and managed care solutions. , A seasoned executive with more ...
(Date:4/24/2017)... ... April 24, 2017 , ... In ... be diagnosed globally; approximately 25,000 of them will be malignant.(1) As research into ... this type of healthcare model in the diagnosis and treatment of brain tumors. ...
(Date:4/24/2017)... ... April 24, 2017 , ... Rod Burkett, CEO of Gardant ... website. , Rod has been at the forefront of Gardant since it was founded ... Rod has overseen the opening of more than 40 new senior living communities. With ...
(Date:4/24/2017)... ... April 24, 2017 , ... As a former supermodel known for her ... good news for single women is that she put all the words in her ... 25th. Joan's insight, personal experiences and sparkling sense of humor have inspired her to ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... familiar. This makes it difficult for lab operators and management to assess these ... help them identify wasteful or unnecessary actions. , Created with the help ...
Breaking Medicine News(10 mins):